2022年12月9日，国药集团中国生物杨晓明团队以“COVID-19vaccination boosts the potency and breadth of the immune response against SARS-CoV-2among recovered patients in Wuhan”为题在国际顶级学术期刊Cell Discovery杂志（IF：38.1... 网页链接